20/20 Biolabs, Inc. Common Stock Free Cash Flow Generation Index
20/20 Biolabs, Inc. Common Stock free cash flow generation index. 20/20 Biolabs, Inc. Common Stock (AIDX) has a Free Cash Flow Generation Index of 0.95x as of December 2022. Free cash flow of $5.54 Million represents 1% of operating cash flow ($5.80 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of 20/20 Biolabs, Inc. Common Stock (2022–2022)
Free cash flow generation index of 20/20 Biolabs, Inc. Common Stock from 2022 to 2022. Historical FCF Generation Index trend for 20/20 Biolabs, Inc. Common Stock across 1 annual periods. See 20/20 Biolabs, Inc. Common Stock (AIDX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
20/20 Biolabs, Inc. Common Stock Free Cash Flow Generation Index by Year (2022–2022)
20/20 Biolabs, Inc. Common Stock free cash flow generation index by year from 2022 to 2022. Year-by-year Free Cash Flow Generation Index for 20/20 Biolabs, Inc. Common Stock. For the full cash flow conversion analysis, see 20/20 Biolabs, Inc. Common Stock (AIDX) cash flow conversion.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.95x | $5.54 Million | $5.80 Million | $261.79K | — |